United States Government Publishing Office publisher pbl distributor dst United States National Archives and Records Administration Office of the Federal Register author aut Government Organization text government publication eng FR Regulatory Information 2012_register executive 2012-07-14 article Notices D09002ee1c7fcbd14 D09002ee1c7fcbd8b United States Department of Health and Human Services originator org United States Government Agency or Subagency United States National Institutes of Health originator org United States Government Agency or Subagency This is notice, in accordance with 35 U.S.C. 209(c)(1) and 37 CFR Part 404.7(a)(1)(i), that the National Institutes of Health, Department of Health and Human Services, is contemplating the grant of a co-exclusive license to practice the inventions embodied in U.S. Patent Application 61/042,239 entitled "Human Monoclonal Antibodies Specific for CD22" [HHS Ref. E-080-2008/0-US-01], PCT Application PCT/ US2009/124109 entitled "Human and Improved Murine Monoclonal Antibodies Against CD22" [HHS Ref. E-080-2008/0-PCT-02], US patent application 12/934,214 entitled "Human Monoclonal Antibodies Specific for CD22" [HHS Ref. E-080-2008/0-US-03], and all related continuing and foreign patents/patent applications for the technology family, to Customized Therapeutics. The patent rights in these inventions have been assigned to and/or exclusively licensed to the Government of the United States of America. The prospective co-exclusive licensed territory may be worldwide, and the field of use may be limited to: 77 FR 41792 https://www.govinfo.gov/app/details/FR-2012-07-16/2012-17218 2012-17218 fr16jy12-58 4140-01-P https://www.govinfo.gov/app/details/FR-2012-07-16/2012-17218 https://www.govinfo.gov/content/pkg/FR-2012-07-16/html/2012-17218.htm https://www.govinfo.gov/content/pkg/FR-2012-07-16/pdf/2012-17218.pdf 2 p. 41792 41793 77 FR 41792 Prospective Grant of Co-Exclusive License: The Development of Human Anti-CD22 Monoclonal Antibodies for the Treatment of Human Cancers and Autoimmune Disease; Federal Register Vol. 77, Issue NOTICE 2012-17218 DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health 2012-07-31 4140-01-P 2012-17218 Notice.

This is notice, in accordance with 35 U.S.C. 209(c)(1) and 37 CFR Part 404.7(a)(1)(i), that the National Institutes of Health, Department of Health and Human Services, is contemplating the grant of a co-exclusive license to practice the inventions embodied in U.S. Patent Application 61/042,239 entitled "Human Monoclonal Antibodies Specific for CD22" [HHS Ref. E-080-2008/0-US-01], PCT Application PCT/ US2009/124109 entitled "Human and Improved Murine Monoclonal Antibodies Against CD22" [HHS Ref. E-080-2008/0-PCT-02], US patent application 12/934,214 entitled "Human Monoclonal Antibodies Specific for CD22" [HHS Ref. E-080-2008/0-US-03], and all related continuing and foreign patents/patent applications for the technology family, to Customized Therapeutics. The patent rights in these inventions have been assigned to and/or exclusively licensed to the Government of the United States of America. The prospective co-exclusive licensed territory may be worldwide, and the field of use may be limited to:

Only written comments and/or applications for a license which are received by the NIH Office of Technology Transfer on or before July 31, 2012 will be considered. Co-Exclusive Licenses: Human Anti-CD22 Monoclonal Antibodies for Treatment of Human Cancers and Autoimmune Disease , lambertsond@od.nih.gov Vol. 77, no. 136 Office of the Federal Register, National Archives and Records Administration 2012-07-16 continuing daily deposited born digital 232 p. Table of Contents: AE 2.7: GS 4.107: AE 2.106: KF70.A2 https://www.govinfo.gov/app/details/FR-2012-07-16 P0b002ee182aee55f 0097-6326 0042-1219 0364-1406 769-004-00000-9 000582072 f:fr16jy12 https://www.govinfo.gov/app/details/FR-2012-07-16 https://www.govinfo.gov/content/pkg/FR-2012-07-16/pdf/FR-2012-07-16.pdf https://www.govinfo.gov/content/pkg/FR-2012-07-16/xml/FR-2012-07-16.xml fdlp 41663 41884 DGPO 2012-07-14 2024-06-03 FR-2012-07-16 machine generated eng FR FR-2012-07-16 77 136